CryoCell Historical Income Statement
| CCEL Stock | USD 8.94 0.45 5.30% |
Historical analysis of CryoCell International income statement accounts such as Selling General Administrative of 11.2 M, Total Revenue of 18.4 M or Gross Profit of 27.7 M can show how well CryoCell International performed in making a profits. Evaluating CryoCell International income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of CryoCell International's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining CryoCell International latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether CryoCell International is a good buy for the upcoming year.
CryoCell |
About CryoCell Income Statement Analysis
CryoCell International Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to CryoCell International shareholders. The income statement also shows CryoCell investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
CryoCell International Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts CryoCell International generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of CryoCell International minus its cost of goods sold. It is profit before CryoCell International operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of CryoCell International. It is also known as CryoCell International overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from CryoCell International's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into CryoCell International current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.At this time, CryoCell International's Non Recurring is quite stable compared to the past year.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 21.5M | 22.9M | 26.3M | 27.7M | Total Revenue | 30.3M | 31.3M | 36.0M | 18.4M |
CryoCell International income statement Correlations
Click cells to compare fundamentals
CryoCell International Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CryoCell International income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | (19.2K) | 1.7M | 2.2M | 1.7M | 2.0M | 2.1M | |
| Selling General Administrative | 14.3M | 14.6M | 15.6M | 17.1M | 19.7M | 11.2M | |
| Total Revenue | 31.1M | 28.9M | 30.3M | 31.3M | 36.0M | 18.4M | |
| Gross Profit | 21.5M | 19.9M | 21.5M | 22.9M | 26.3M | 27.7M | |
| Other Operating Expenses | 24.1M | 24.5M | 25.9M | 27.9M | 32.0M | 17.4M | |
| Operating Income | 7.7M | 4.0M | 4.0M | (12.3M) | (14.1M) | (13.4M) | |
| Ebit | 7.7M | 4.0M | 4.0M | 3.5M | 4.0M | 4.2M | |
| Ebitda | 7.6M | 5.7M | 6.3M | 5.2M | 6.0M | 6.3M | |
| Cost Of Revenue | 9.7M | 9.0M | 8.8M | 8.4M | 9.7M | 5.6M | |
| Total Operating Expenses | 14.5M | 15.5M | 17.1M | 19.4M | 22.3M | 12.0M | |
| Income Before Tax | 5.0M | 2.6M | 3.3M | (13.4M) | (15.4M) | (14.6M) | |
| Total Other Income Expense Net | (2.6M) | (1.4M) | (705.5K) | (15.6M) | (14.1M) | (13.4M) | |
| Net Income | 3.6M | 2.1M | 2.8M | (9.5M) | (10.9M) | (10.4M) | |
| Income Tax Expense | 1.4M | 527.7K | 547.5K | (3.8M) | (4.4M) | (4.2M) | |
| Research Development | 23.9K | 49.9K | 384.8K | 1.2M | 1.3M | 1.4M | |
| Interest Expense | 1.5M | 1.4M | 1.5M | 1.2M | 1.4M | 1.2M | |
| Net Income Applicable To Common Shares | 2.3M | 3.6M | 2.1M | 2.8M | 3.2M | 2.1M | |
| Net Income From Continuing Ops | 3.6M | 2.1M | 2.8M | (9.5M) | (8.6M) | (8.1M) | |
| Tax Provision | 1.4M | 527.7K | 547.5K | (3.8M) | (3.5M) | (3.3M) | |
| Net Interest Income | (1.5M) | (1.4M) | (1.5M) | (1.2M) | (1.1M) | (1.2M) | |
| Reconciled Depreciation | 636.0K | 1.3M | 1.8M | 1.7M | 2.0M | 1.0M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as CryoCell International using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Additional Information and Resources on Investing in CryoCell Stock
When determining whether CryoCell International is a strong investment it is important to analyze CryoCell International's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CryoCell International's future performance. For an informed investment choice regarding CryoCell Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.25) | Earnings Share (1.16) | Revenue Per Share 3.783 | Quarterly Revenue Growth 0.004 | Return On Assets (0.01) |
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.